⌘K

Login Start Free

Home/Filings/4/0001127602-21-029962

4//SEC Filing

Hollingshead James 4

Accession 0001127602-21-029962

CIK 0000943819other

View on SEC.gov Company Profile

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 7:16 PM ET

Size

4.4 KB

Accession

0001127602-21-029962

Insider Transaction Report

Form 4

Period: 2021-12-01

Hollingshead James

President, Americas

Transactions

Sale
ResMed Common Stock
2021-12-01$256.84/sh−2,400$616,416→ 76,721 total

Footnotes (1)

[F1]The transaction was conducted under a Rule 10b5-1 plan.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

RESMED INC

CIK 0000943819

Entity typeother

Related Parties

1

filerCIK 0001570610

Filing Metadata

Form type: 4
Filed: Nov 30, 7:00 PM ET
Accepted: Dec 1, 7:16 PM ET
Size: 4.4 KB

View on SEC.gov